Authors:
PETZER AL
GUNSILIUS E
ZECH N
CLAUSEN J
HOFLEHNER E
GASTL G
Citation: Al. Petzer et al., EVALUATION OF OPTIMAL OVERNIGHT STORAGE-CONDITIONS FOR MATURE (CFC) AND IMMATURE (LTC-IC) PROGENITOR CELLS IN APHERESIS PRODUCTS, Experimental hematology, 26(8), 1998, pp. 374-374
Authors:
HILBE W
APFELBECK U
FRIDRIK M
BERNHART M
NIESSNER H
ABBREDERIS K
MICHLMAYR G
PONT J
LINKESCH W
HAUSMANINGER H
ARNEITZ K
BALDINGER C
DUBA C
EISTERER W
GREIL R
KONWALINKA G
NIEDERWIESER D
GASTL G
THALER J
Citation: W. Hilbe et al., INTERFERON-ALPHA FOR THE TREATMENT OF ELDERLY PATIENTS WITH CHRONIC MYELOID-LEUKEMIA, Leukemia research, 22(10), 1998, pp. 881-886
Citation: C. Ludescher et al., DIFFERENTIAL ACTIVITY OF P-GLYCOPROTEIN IN NORMAL BLOOD LYMPHOCYTE SUBSETS, British Journal of Haematology, 101(4), 1998, pp. 722-727
Citation: E. Gunsilius et al., HIGH-DOSE THERAPY WITH AUTOLOGOUS PERIPHE RAL STEM-CELL TRANSPLANTATION .2. INDICATIONS AND CLINICAL-RESULTS, Acta medica austriaca, 24(3), 1997, pp. 102-107
Authors:
THURNHER M
PAPESH C
RAMONER R
GASTL G
BOCK G
RADMAYR C
KLOCKER H
BARTSCH G
Citation: M. Thurnher et al., IN-VITRO GENERATION OF CD83(-TUMOR IMMUNOTHERAPY() HUMAN BLOOD DENDRITIC CELLS FOR ACTIVE), Experimental hematology, 25(3), 1997, pp. 232-237
Authors:
ROHDE D
GASTL G
BIESTERFELD S
PLANTE M
JAKSE G
Citation: D. Rohde et al., LOCAL EXPRESSION OF CYTOKINES IN RAT BLADDER-CARCINOMA TISSUE AFTER INTRAVESICAL TREATMENT WITH NOCARDIA-RUBRA CELL-WALL SKELETON AND BACILLUS-CALMETTE-GUERIN, Urological research, 25(1), 1997, pp. 19-24
Authors:
THURNHER M
RAMONER R
GASTL G
RADMAYR C
BOCK G
HEROLD M
KLOCKER H
BARTSCH G
Citation: M. Thurnher et al., BACILLUS-CALMETTE-GUERIN MYCOBACTERIA STIMULATE HUMAN BLOOD DENDRITICCELLS, International journal of cancer, 70(1), 1997, pp. 128-134
Authors:
MARTH C
ZEIMET AG
WIDSCHWENDTER M
LUDESCHER C
KAERN J
TROPE C
GASTL G
DAXENBICHLER G
DAPUNT O
Citation: C. Marth et al., PACLITAXEL-DEPENDENT AND DOCETAXEL-DEPENDENT ACTIVATION OF CA-125 EXPRESSION IN HUMAN OVARIAN-CARCINOMA CELLS, Cancer research, 57(17), 1997, pp. 3818-3822
Citation: Pj. Effert et al., CURRENT AND FUTURE STRATEGIES TO BLOCK TUMOR ANGIOGENESIS, INVASION, AND METASTASIS, World journal of urology, 14(3), 1996, pp. 131-140
Authors:
GASTL G
EBERT T
FINSTAD CL
SHEINFELD J
GOMAHR A
AULITZKY W
BANDER NH
Citation: G. Gastl et al., MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I AND CLASS-II EXPRESSION IN RENAL-CELL CARCINOMA AND MODULATION BY INTERFERON-GAMMA, The Journal of urology, 155(1), 1996, pp. 361-367
Authors:
EIBL B
GREITER E
GRUNEWALD K
GASTL G
WEYRER K
THALER J
AULITZKY W
HERRMANN F
RAPP U
HUBER C
Citation: B. Eibl et al., EXPRESSION OF C-FOS CORRELATES WITH IFN-ALPHA RESPONSIVENESS IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA, Cytokines and molecular therapy, 1(1), 1995, pp. 29-38
Citation: Al. Kranich et al., SYMPOSIUM ON HEALTH ECONOMICS IN ONCOLOGY - FREIBURG, GERMANY, JUNE 1995, Journal of cancer research and clinical oncology, 121(11), 1995, pp. 691-693
Citation: Al. Kranich et al., SYMPOSIUM ON QUALITY ASSURANCE AND GOOD CLINICAL-PRACTICE (GCP) IN CANCER DRUG DEVELOPMENT, Journal of cancer research and clinical oncology, 120(10), 1994, pp. 625-627
Authors:
THALER J
GASTL G
FLUCKINGER T
NIEDERWIESER D
HUBER H
SEEWANN H
SILLY H
LANG A
ABBREDERIS C
GADNER H
FEREBERGER W
SCHILLER L
KOCK L
FRIDRIK M
DUBA C
FALK M
BERGER M
KUHR T
HUBER C
Citation: J. Thaler et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALFA-2C - RESPONSE RATE AND TOXICITY IN A PHASE-II MULTICENTER STUDY, Seminars in hematology, 30(3), 1993, pp. 17-19